0001437749-23-017587.txt : 20230615
0001437749-23-017587.hdr.sgml : 20230615
20230615183506
ACCESSION NUMBER: 0001437749-23-017587
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230601
FILED AS OF DATE: 20230615
DATE AS OF CHANGE: 20230615
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Scott John K Jr.
CENTRAL INDEX KEY: 0001753763
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35076
FILM NUMBER: 231018907
MAIL ADDRESS:
STREET 1: 30 BLUE HERON DR.
CITY: GREENWOOD VILLAGE
STATE: CO
ZIP: 80121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NAVIDEA BIOPHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000810509
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 311080091
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4995 BRADENTON AVENUE
STREET 2: SUITE 240
CITY: DUBLIN
STATE: OH
ZIP: 43017
BUSINESS PHONE: 6147937500
MAIL ADDRESS:
STREET 1: 4995 BRADENTON AVENUE
STREET 2: SUITE 240
CITY: DUBLIN
STATE: OH
ZIP: 43017
FORMER COMPANY:
FORMER CONFORMED NAME: NEOPROBE CORP
DATE OF NAME CHANGE: 19940714
4
1
rdgdoc.xml
FORM 4 SCOTT 06.15.23
X0407
4
2023-06-01
0000810509
NAVIDEA BIOPHARMACEUTICALS, INC.
NAVB
0001753763
Scott John K Jr.
4995 BRADENTON AVE., SUITE 240
DUBLIN
OH
43017
1
1
0
Series G Redeemable Preferred Stock
2023-06-01
4
J
0
990
D
2270
D
Common Stock
2023-06-05
4
A
0
11508672
A
19555832
D
Common Stock
10139
I
By spouse and children
Series J Convertible Preferred Stock
0.1040
2023-06-01
4
P
0
11969
100
A
2023-06-01
Common Stock
11508672
11969
D
Series J Convertible Preferred Stock
0.1040
2023-06-05
4
C
0
11969
100
D
2023-06-01
Common Stock
11508672
0
D
Navidea entered into a Stock Exchange Agreement with the Reporting Person, pursuant to which he surrendered 990 shares of Series G Redeemable Preferred Stock, par value $.001 per share, and $68,853.22 of accrued and unpaid dividends thereon in exchange for 11,969 shares of Series J Convertible Preferred Stock, par value $.001 per share.
Series J Convertible Preferred Stock, par value $.001 per share was converted into Common Stock.
Includes 2,639 shares of Common Stock owned by the Reporting Person's spouse and 7,500 shares of Common Stock owned by the Reporting Person's children. The Reporting Person may be deemed tohave shared voting and/or dispositive power with respect to such shares.
Series J Convertible Preferred Stock, par value $.001 per share, is convertible at any time and has no expiration date.
The Reporting Person converted 11,969 shares of Series J Convertible Preferred Stock, par value $.001 per share, into 11,508,672 shares of Common Stock.
/s/ Joseph W. Meyer for John K. Scott, Jr. by power of attorney
2023-06-15